UPDATED Apr 17, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BANI | €3.38 | 0% | -13.3% | €38.0m | €4.50 | PS6.1x | E111.5% | 0% | Real Estate Management and Development | ||
HYL | €11.95 | -3.6% | -13.7% | €334.6m | €21.55 | PS118.9x | E42.8% | n/a | Pharmaceuticals & Biotech | ||
ATEB | €6.05 | -4.9% | -87.0% | €262.7m | €13.40 | PS2.9x | E118.6% | 0% | Real Estate Management and Development | ||
IBAB | €13.08 | -3.3% | -18.0% | €381.6m | €16.17 | PB4.4x | E85.4% | 1.6% | Healthcare | ||
EKOP | €18.45 | -2.4% | 1.9% | €273.5m | €27.50 | PS7.6x | E93.5% | n/a | Commercial Services | ||
IMMO | €26.60 | -8.3% | -44.5% | €265.3m | €46.00 | PS1.7x | E110.8% | 4.5% | Real Estate Management and Development | ||
MITRA | €0.22 | -3.1% | -92.5% | €15.2m | n/a | PE-0.09x | E105.1% | 0% | Pharmaceuticals & Biotech | ||
ABO | €5.50 | -4.3% | -3.5% | €58.1m | €7.00 | PE23x | E31.6% | n/a | Commercial Services | ||
UPG | €3.86 | -10.2% | -16.1% | €138.3m | €4.65 | PB1.8x | E84.7% | n/a | Software | ||
HYSG | €3.38 | -4.0% | -29.6% | €111.0m | €5.15 | PE84.2x | E73.8% | n/a | Software |